Dark

Check out our Level2View

CFMS
Conformis, Inc. Common Stock
stock NASDAQ

Inactive

Sep 1, 2023

2.26USD0.000%(0.00)7,081

Pre-market

0.00USD-100.000%(-2.26)0

After-hours

0.00USD0.000%(0.00)0

OverviewHistoricalExchangesShortsNews

Jan 20, 2022

04:30PM EST Conformis, Inc. (NASDAQ: CFMS) announced today that as mentioned on its Business Update call on January 6, 2022, it will release its financial results for the fourth quarter and fiscal year ended December 31, 2021, after the market closes on Wednesday, March 2, 2022, at approximately 4:00 p.m. Eastern Time. GlobeNewswire Inc

Jan 6, 2022

07:18AM EST Conformis Sees Q4 Product Revenue Of $15.3M Benzinga

07:00AM EST Company Launches Innovative Image-to-Implant Platinum Services Program to Better Serve Patients and Surgeons GlobeNewswire Inc

Jan 4, 2022

08:33AM EST Conformis, Inc. To Provide Business Update And Initial Expectations For 2022 On January 6, 2022 Benzinga

08:30AM EST Conformis, Inc. (NASDAQ: CFMS) announced today that it will provide a business update and initial expectations for 2022 before the market opens on Thursday, January 6, 2022, at approximately 7:00 a.m. Eastern Time. GlobeNewswire Inc

Dec 23, 2021

08:35AM EST Conformis Chief Legal Officer Brent Alldredge Departing On Jan 16 To Become The General Counsel At Bruker Corp RTTNews

08:30AM EST Conformis, Inc.(NASDAQ:CFMS) announced today that Brent Alldredge, Chief Legal Officer and Corporate Secretary, has notified the Company that he will be departing the Company on January 16, 2022 to become the General Counsel at Bruker Corporation, a global, publicly traded developer, manufacturer, and distributor of scientific instruments and analytical and diagnostic solutions. GlobeNewswire Inc

Nov 15, 2021

11:17AM EST Conformis Receives FDA 510 Approval For Identity Imprint Cruciate Retaining Knee Replacement System Benzinga

Nov 8, 2021

09:00AM EST Conformis, Inc.(NASDAQ:CFMS) announced today that the Company has appointedJames Paivaas its new Vice President, U.S. Marketing. GlobeNewswire Inc

Nov 4, 2021

10:02AM EDT Oppenheimer Maintains Outperform on Conformis, Lowers Price Target to $2 Benzinga

Nov 3, 2021

05:57PM EDT Conformis Sees Q4 Sales $15M-$17M Vs. $18.39M Est. Benzinga

05:56PM EDT Conformis Q3 EPS $(0.07) Misses $(0.06) Estimate, Sales $14.25M Miss $14.61M Estimate Benzinga

09:10AM EDT Earnings Scheduled For November 3, 2021 Benzinga

Oct 22, 2021

10:13AM EDT Hearing TheStreet Names Conformis An Under $10 Stock To Buy Benzinga

Oct 4, 2021

05:00PM EDT Conformis, Inc. (NASDAQ: CFMS) announced today that it will release its financial results for the third quarter ended September 30, 2021 after the market closes on November 3, 2021 at approximately 4:00 p.m. Eastern Time. GlobeNewswire Inc

Sep 30, 2021

09:24AM EDT Conformis Posts Clinical Study Data For Its Knee Implants Benzinga

Sep 29, 2021

05:02PM EDT Conformis, Inc. Announces Clinical Study Results for Its Personalized Knee Implants Benzinga

05:00PM EDT Conformis, Inc. (NASDAQ:CFMS) announced today the strong results of a published retrospective study of procedures using Conformis patient-specific iTotal CR (cruciate-retaining) knee replacement implant, which assessed implant survivorship, patient satisfaction, and functional outcomes. GlobeNewswire Inc

Sep 27, 2021

10:54AM EDT Conformis Receives FDA 510K Approval For Identity Imprint Knee Replacement System Benzinga

Sep 22, 2021

07:21AM EDT Oppenheimer Maintains Outperform on Conformis, Lowers Price Target to $2.5 Benzinga

Sep 20, 2021

04:32PM EDT Conformis Cuts Q3 Sales Guidance From $15.5M-$16.5M To $13.7M-$14.3M Vs. $16.23M Est. Benzinga

04:30PM EDT Conformis, Inc. Provides Business Update GlobeNewswire Inc

Sep 7, 2021

05:00PM EDT Conformis, Inc.(NASDAQ: CFMS), an orthopedic medical device company that features a range of personalized knee and hip replacement products, announced today that Mark Augusti, Chief Executive Officer, and Bob Howe, Chief Financial Officer, will participate in two virtual investor conferences in September 2021. GlobeNewswire Inc

Aug 20, 2021

02:00PM EDT Return on Capital Employed Overview: Conformis Benzinga

Aug 18, 2021

05:02PM EDT Conformis, Inc. Announces First Procedure Performed Using the Identity Imprint Knee Replacement System Benzinga

05:00PM EDT Conformis, Inc.(NASDAQ:CFMS) today announced the first procedure with the new Conformis Identity Imprint knee replacement system. GlobeNewswire Inc

Aug 4, 2021

04:53PM EDT Conformis Sees Q3 Sales $15.5M-$16.5M vs $17.21M Est. Benzinga

04:51PM EDT Conformis Q2 EPS $0.21 Beats $0.04 Estimate, Sales $56.30M Beat $33.00M Estimate Benzinga

04:05PM EDT Conformis, Inc. (NASDAQ:CFMS), an orthopedic medical device company that features personalized knee and hip replacement products, announced today financial results for the second quarter ended June30, 2021. GlobeNewswire Inc

04:10AM EDT Earnings Scheduled For August 4, 2021 Benzinga

Aug 3, 2021

11:07AM EDT A Preview Of Conformis's Earnings Benzinga

Jul 14, 2021

05:45PM EDT Conformis, Inc.(NASDAQ: CFMS), an orthopedic medical device company that features personalized knee and hip replacement products, announced today that Mark Augusti, Chief Executive Officer, and Bob Howe, Chief Financial Officer, will present at the Canaccord Genuity 40th Annual Growth Conference. GlobeNewswire Inc

Jul 7, 2021

07:35AM EDT Conformis, Inc. Announces Settlement Of Wright Medical Patent Litigation; Stryker To Make One-Time Payment To Conformis And Be Granted Non-Exclusive License With Respect T Certain Patents, Payment Size Not Disclosed Benzinga

07:30AM EDT Conformis, Inc. (NASDAQ:CFMS) announced today that it has entered into a settlement with Stryker Corporation (Stryker) resolving patent litigation involving Wright Medical Technology, Inc. and Tornier, Inc. (together, Wright Medical). Stryker acquired Wright Medical in November 2020. GlobeNewswire Inc

Jul 1, 2021

05:00PM EDT Conformis, Inc. (NASDAQ: CFMS) announced today that it will release its financial results for the second quarter ended June 30, 2021 after the market closes on August 4, 2021 at approximately 4:00 p.m. Eastern Time. GlobeNewswire Inc

Jun 23, 2021

07:32AM EDT Conformis, Inc. Announces Exclusive Distribution Agreement With XR Medical Group in China Benzinga

07:30AM EDT Conformis, Inc.(NASDAQ:CFMS) today announced the execution of an agreement to enter the Asia-Pacific market through an exclusive distribution relationship with XR Medical Group (Hong Kong) Limited (XR Medical). GlobeNewswire Inc

Jun 3, 2021

04:56PM EDT Conformis Shares Spike Higher; Traders Circulate Docdroid.com Link Showing Co Files Patent Infringement Lawsuit Against Bodycad, Exactech Benzinga

May 18, 2021

08:15AM EDT Conformis, Inc.(NASDAQ: CFMS), an orthopedic medical device company that features personalized knee and hip replacement products, announced today that Mark Augusti, Chief Executive Officer, will present at the Oppenheimer MedTech, Tools & Diagnostics Summit. GlobeNewswire Inc

May 12, 2021

06:10PM EDT Conformis, Inc.(NASDAQ: CFMS), an orthopedic medical device company that features personalized knee and hip replacement products, announced today that Mark Augusti, Chief Executive Officer, and Bob Howe, Chief Financial Officer, will present at the Canaccord Genuity Musculoskeletal Conference. GlobeNewswire Inc

May 10, 2021

01:35PM EDT MedTech Round Up: Update On Products By Conformis, Medtronic, Orthofix, Neovasc Benzinga

07:31AM EDT Conformis, Inc. Announces FDA 510(k) Clearance For Identity Imprint Knee Replacement System Benzinga

07:30AM EDT Conformis, Inc.(NASDAQ:CFMS) today announced 510(k) clearance by theU.S. Food and Drug Administrationfor the Companys Identity Imprint Knee Replacement System. GlobeNewswire Inc

May 5, 2021

04:35PM EDT Conformis: Q1 Earnings Insights Benzinga

04:35PM EDT Conformis Sees Q2 2021 Product Revs $14M-$14.5M Benzinga

04:33PM EDT Conformis Q1 EPS $(0.09) Misses $(0.07) Estimate, Sales $13.84M Beat $13.77M Estimate Benzinga

04:05PM EDT Conformis, Inc. (NASDAQ:CFMS), an orthopedic medical device company that features personalized knee and hip replacement products, announced today financial results for the first quarter ended March31, 2021. GlobeNewswire Inc

04:16AM EDT Earnings Scheduled For May 5, 2021 Benzinga

May 4, 2021

10:24AM EDT Conformis's Earnings: A Preview Benzinga

Apr 22, 2021

04:32PM EDT Conformis Reports Received 510(k) Clearance By FDA For Patient-Specific Instrumentation Development By Co. Under Its License Deal With Howmedica Osteonics Benzinga

04:30PM EDT Conformis Announces Achievement of Third Milestone Under GlobeNewswire Inc

Apr 19, 2021

04:52PM EDT Conformis Enters License Agreement With Paragon 28, Inc. RTTNews

04:30PM EDT Conformis, Inc. (NASDAQ:CFMS) announced today that it has entered into a license agreement with Paragon 28, Inc., granting Paragon 28 a non-exclusive license under a subset of Conformis U.S. patents for the use of patient-specific instruments with off-the-shelf implants in Paragon 28s APEX 3D Total Ankle Replacement System. GlobeNewswire Inc

Apr 7, 2021

07:30AM EDT Conformis, Inc. (NASDAQ: CFMS) announced today that it will release its financial results for the first quarter ended March 31, 2021 after the market closes on May 5, 2021 at approximately 4:00 p.m. Eastern Time. GlobeNewswire Inc

Mar 16, 2021

07:00AM EDT Conformis, Inc. (NASDAQ:CFMS) announced today that an independent, retrospective review of hospital data has concluded that Conformis iTotal knee replacement technology is more cost-effective than leading traditional, off-the-shelf implants. Importantly, this study was independently performed with no sponsorship or funding from Conformis. GlobeNewswire Inc

Mar 4, 2021

08:01AM EST Hearing Canaccord Says Conformis Is 'undervalued despite momentum'; Unconfirmed Benzinga

Mar 3, 2021

04:11PM EST Conformis Sees Q1 Sales $13M-$14M Vs. $16.68M Est. Benzinga

04:11PM EST Conformis Q4 EPS $(0.08) Beats $(0.10) Estimate, Sales $16.70M Miss $17.68M Estimate Benzinga

04:05PM EST Conformis, Inc. (NASDAQ:CFMS) announced today financial results for the fourth quarter and year ended December31, 2020. GlobeNewswire Inc

03:43AM EST Earnings Scheduled For March 3, 2021 Benzinga

Mar 2, 2021

10:05AM EST Conformis's Earnings Outlook Benzinga

Mar 1, 2021

05:45PM EST Conformis, Inc.(NASDAQ: CFMS) today announced the clearance of its patient-specific iTotal PS total knee replacement system by the Therapeutic Goods Administration, which is part of the Australian Department of Health, and which authorizes the marketing of medical devices and other healthcare products in Australia. GlobeNewswire Inc

Feb 25, 2021

08:00AM EST Conformis, Inc.(NASDAQ: CFMS), a leading medical device company that features personalized knee and hip replacement products, announced today that Mark Augusti, Chief Executive Officer, and Bob Howe, Chief Financial Officer, will participate at two upcoming virtual investor conferences. GlobeNewswire Inc

Feb 18, 2021

04:51PM EST Conformis 8-K Shows Co. Regained Compliance With Nasdaq Benzinga

Feb 12, 2021

08:34AM EST Conformis Prices 80,952,381 Share Common Stock Offering At $1.05/Share Benzinga

08:30AM EST Conformis, Inc. Announces Pricing of $85 Million Underwritten GlobeNewswire Inc

Feb 11, 2021

04:29PM EST Conformis Sees Prelim. Q4 Sales $16.7M vs $18.23M Est., FY20 Sales $68.8M vs $70.45M Est. Benzinga

04:05PM EST Conformis Announces Proposed Public Offering of Common Stock; Size And Price Not Disclosed Benzinga

04:01PM EST Conformis, Inc. Announces Proposed Public Offering of Common Stock GlobeNewswire Inc

Jan 21, 2021

04:16PM EST Conformis, Inc. and SITES Medical Announce Development & Supply Agreement Benzinga

04:15PM EST Conformis, Inc. and SITES Medical Announce Development & Supply GlobeNewswire Inc

Jan 7, 2021

08:00AM EST Conformis, Inc. (NASDAQ: CFMS) announced today that it will release its financial results for the fourth quarter and fiscal year ended December 31, 2020 after the market closes on March 3, 2021 at approximately 4:00 p.m. Eastern Time. GlobeNewswire Inc

Dec 31, 2020

08:30AM EST Conformis, Inc. (NASDAQ: CFMS), a leader in patient-specific knee and hip instrumentation and implants, announced today that Mark Augusti, Chief Executive Officer, and Bob Howe, Chief Financial Officer, will participate in two virtual investor conferences in January 2021. GlobeNewswire Inc

Dec 17, 2020

04:15PM EST Conformis Announces U.S. Commercial Launch of Cordera Match Hip System Benzinga

04:15PM EST Conformis, Inc.(NASDAQ: CFMS) announced today the U.S. commercial launch of the Companys new CorderaMatch Hip System. The Company previously announced 510(k) clearance by theU.S. Food and Drug Administration for the CorderaHip System on September 29, 2020, and CorderaMatch represents one of multiple planned product extensions featuring the proven Cordera Hip System. GlobeNewswire Inc

Nov 24, 2020

04:30PM EST Conformis, Inc.(NASDAQ:CFMS) announced today thatMark Augusti, President and Chief Executive Officer, andRobert Howe, Chief Financial Officer, will participate in the 32nd Annual 2020 Piper Sandler Virtual Healthcare Conference taking placeDecember 1-3, 2020. Conformis will provide an investor presentation and will be available for virtual one-on-one meetings during the conference. GlobeNewswire Inc

Nov 4, 2020

04:41PM EST Conformis Q3 EPS $(0.09) Beats $(0.12) Estimate, Sales $16.10M Beat $14.42M Estimate Benzinga

04:10PM EST Conformis, Inc. (NASDAQ:CFMS) announced today financial results for the third quarter ended September30, 2020. GlobeNewswire Inc

04:41AM EST Earnings Scheduled For November 4, 2020 Benzinga

Nov 3, 2020

10:09AM EST Earnings Outlook for Conformis Benzinga

Oct 6, 2020

07:46AM EDT Conformis Q3 Total Revenue $16.1 Mln, Down 7% Year-over-year On Reported And CC Basis RTTNews

07:39AM EDT Conformis Expects Q3 Sales ~$16.1M Vs. $13.02M Est. Benzinga

07:30AM EDT Conformis, Inc. (NASDAQ:CFMS) today announced preliminary, unaudited, revenue results for the third quarter ended September 30, 2020. GlobeNewswire Inc

Sep 29, 2020

11:08AM EDT Conformis Reports 510(k) Clearance For Cordera Hip System RTTNews

10:46AM EDT Conformis Announces 510(K) Clearance For Cordera Hip System Benzinga

10:45AM EDT Conformis, Inc.(NASDAQ: CFMS) today announced 510(k) clearance by theU.S. Food and Drug Administrationof the Companys new Cordera Hip System. The first product in the Conformis hip product line, the Conformis Hip System, was launched commercially in November 2019 and provided a patient-specific stem. GlobeNewswire Inc

Sep 24, 2020

07:26AM EDT Conformis Announces $17.25 Mln Registered Direct Offering RTTNews

07:05AM EDT Conformis, Inc. Announces $17.25M Registered Direct Offering Priced At-The-Market Benzinga

07:00AM EDT Conformis, Inc. Announces $17.25 Million Registered Direct GlobeNewswire Inc

Sep 16, 2020

04:30PM EDT Conformis, Inc. (NASDAQ:CFMS) will participate in the 2020 Oppenheimer Fall Healthcare Life Sciences & MedTech Summit being held September 21-23, 2020 in a virtual format. Mark Augusti, President and Chief Executive Officer, and Robert Howe, Chief Financial Officer, will represent the Company in a session scheduled to begin at 2:30 pm ET on Tuesday, September 22, 2020. GlobeNewswire Inc

Sep 8, 2020

04:30PM EDT Conformis, Inc. (NASDAQ:CFMS) will participate in the upcoming 2020 H.C. Wainwright 22nd Annual Global Investment Conference, to be held virtually on September 14-16, 2020. Mark Augusti, President and Chief Executive Officer, and members of the Companys management team, will present on Tuesday, September 15, 2020, in a session scheduled to begin at 2:30 p.m. ET. GlobeNewswire Inc

Sep 2, 2020

05:30PM EDT Conformis, Inc. (NASDAQ:CFMS) announced today that Mark Augusti, President and Chief Executive Officer, and members of the Companys executive management team will participate in the 2020 Wells Fargo Virtual Healthcare Conference taking place September 9-10, 2020, in one-on-one meetings. GlobeNewswire Inc

Aug 20, 2020

07:38AM EDT Conformis Reports Achievement Of Second Milestone Under Agreements With Stryker RTTNews

07:35AM EDT Conformis Announces Achievement Of Second Milestone Under Development And License Agreements, Will Receive An Additional $3M From Stryker For Achieving Milestone Benzinga

07:30AM EDT Conformis Announces Achievement of Second Milestone Under GlobeNewswire Inc

Aug 13, 2020

05:15PM EDT Conformis, Inc. (NASDAQ:CFMS) announced today that the Company has appointed Farzin Khaghani as its new VP, US Marketing. GlobeNewswire Inc

Aug 10, 2020

09:25AM EDT Conformis, Inc. (NASDAQ:CFMS) announced today that 90% of the patients studied in peer-reviewed clinical research published online in The Journal of Bone and Joint Surgery Reviews were satisfied, or very satisfied, 1828 months post-surgery. In addition, 88% of patients reported that their knees felt natural either some or all of the time. GlobeNewswire Inc

Aug 5, 2020

05:01PM EDT Conformis Q2 EPS $(0.03) Beats $(0.10) Estimate, Sales $19.50M Down From $19.59M YoY Benzinga

04:21AM EDT Earnings Scheduled For August 5, 2020 Benzinga

Share